(Q40766761)

English

Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine (English)

1 reference

Europe PubMed Central

23 September 2017

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

author name string

B Lehner

1

1 reference

Europe PubMed Central

23 September 2017

P Schlag

2

1 reference

Europe PubMed Central

23 September 2017

W Liebrich

3

1 reference

Europe PubMed Central

23 September 2017

V Schirrmacher

4

1 reference

Europe PubMed Central

23 September 2017

publication date

1 January 1990

1 reference

Europe PubMed Central

23 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

23 September 2017

32

1 reference

Europe PubMed Central

23 September 2017

3

1 reference

Europe PubMed Central

23 September 2017

173-178

1 reference

Europe PubMed Central

23 September 2017

https://scigraph.springernature.com/pub.10.1007/bf01771453

0 references

Modification of tumor cells by a low dose of Newcastle disease virus. II. Augmented tumor-specific T cell response as a result of CD4+ and CD8+ immune T cell cooperation

1 reference

https://api.crossref.org/works/10.1007%2FBF01771453

21 January 2018

Interferon Production by Individual L Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of HLA-D-region antigens by two-dimensional gel electrophoresis. Molecular-genotyping

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active specific immunotherapy of Dukes B2 and C colorectal carcinoma: comparison of two doses of the vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon induction by viruses. X. A model for interferon induction by Newcastle disease virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additiona

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A low-viscosity epoxy resin embedding medium for electron microscopy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Newcastle disease virus stimulates the cellular accumulation of stress (heat shock) mRNAs and proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Viral oncolysate in the management of malignant melanoma. II. Clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incorporation studies of nucleic acid precursors in gastric cancer: an attempt in individualized chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD30(Ki-1) antigen expression in a subset of gastric mucosal plasma cells and in a primary gastric plasmacytoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of direct extension of carcinoma of the colon and rectum

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Newcastle disease virus as an antineoplastic agent: induction of tumor necrosis factor-alpha and augmentation of its cytotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy trials: current status and future directions with special emphasis on biologic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of autoantigens in human colorectal carcinomas. Implications for a generic vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NEWCASTLE DISEASE VIRUS AS AN ANTINEOPLASTIC AGENT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation Kinetics of X-irradiated Mouse L Cells Studied with Time-lapse Photography. II

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of tumor cells by a low dose of Newcastle disease virus. Augmentation of the tumor-specific T cell response in the absence of an anti-viral response

1 reference

https://pubmed.ncbi.nlm.nih.gov/2289211

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01771453

1 reference

Europe PubMed Central

23 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40766761&oldid=1906910098"